BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9543063)

  • 1. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation.
    Bilgrami S; Feingold JM; Dorsky D; Edwards RL; Clive J; Tutschka PJ
    Bone Marrow Transplant; 1998 Mar; 21(6):591-5. PubMed ID: 9543063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
    Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
    Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
    Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
    Kersun LS; Propert KJ; Lautenbach E; Bunin N; Demichele A
    Pediatr Blood Cancer; 2005 Aug; 45(2):162-9. PubMed ID: 15593235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
    Toor AA; van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clarithromycin in preventing viridans streptococcal bacteremia following autologous stem cell transplantation.
    Naqvi B; Dorsky D; Ali SA; Feingold JM; Edwards RL; Bona RD; Clive J; Tutschka PJ; Bilgrami S
    Infection; 2001 Aug; 29(4):201-4. PubMed ID: 11545480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation.
    Bilgrami S; Feingold JM; Dorsky D; Edwards RL; Bona RD; Khan AM; Rodriguez-Pinero F; Clive J; Tutschka PJ
    Bone Marrow Transplant; 1999 May; 23(10):1039-42. PubMed ID: 10373070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance.
    Bilgrami S; Aslanzadeh J; Feingold JM; Bona RD; Clive J; Dorsky D; Edwards RL; Tutschka PJ
    Bone Marrow Transplant; 1999 Jul; 24(1):69-73. PubMed ID: 10435738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
    Ahmed R; Hassall T; Morland B; Gray J
    Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
    Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
    Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
    Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
    Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
    Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
    Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
    J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study.
    Engelhard D; Elishoov H; Or R; Naparstek E; Nagler A; Strauss N; Cividalli G; Aker M; Ramu N; Simhon A
    Bone Marrow Transplant; 1995 Oct; 16(4):565-70. PubMed ID: 8528173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of bacteremia caused by streptococci of the viridans group].
    Ruiz MP; Soriano F
    Enferm Infecc Microbiol Clin; 1994 Nov; 12(9):426-32. PubMed ID: 7811768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.